https://orcid.org/0000-0001-6559-686X
References
- Human Coronavirus Types: Centers for Disease Control and Prevention; 2020 [updated 2020 Feb 15; cited 2020 Apr 14]. Available from: https://www.cdc.gov/coronavirus/types.html
- Okba NMA, Muller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 2020 Apr 8;26(7). doi: 10.3201/eid2607.200841
- Coronavirus disease (COVID-19) Pandemic World Health Organization: World Health Organization; 2020 [cited 2020 Apr 14]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
- Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Mar 4;181(2):271–280. doi: 10.1016/j.cell.2020.02.052
- Klasse PJ. Neutralization of virus infectivity by antibodies: old problems in new perspectives. Adv Biol. 2014. doi: 10.1155/2014/157895
- Pascal KE, Dudgeon D, Trefry JC, et al. Development of clinical-stage human monoclonal antibodies that treat advanced ebola virus disease in nonhuman primates. J Infect Dis. 2018 Nov 22;218(suppl_5):S612–S626. doi: 10.1093/infdis/jiy285
- Zellweger RM, Prestwood TR, Shresta S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe. 2010 Feb 18;7(2):128–139. doi: 10.1016/j.chom.2010.01.004